GSK plc Files Form 6-K for Share Transactions
Ticker: GLAXF · Form: 6-K · Filed: Jun 20, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, sec-filing, foreign-private-issuer
TL;DR
GSK filed a 6-K on 6/20/25 about share transactions.
AI Summary
GSK plc announced a transaction in its own shares on June 20, 2025. The company, formerly known as GlaxoSmithKline PLC, is filing a Form 6-K report with the SEC, indicating it will file annual reports under Form 20-F. The filing details are for the month of June 2025.
Why It Matters
This filing provides transparency regarding GSK's activities in its own shares, which can be relevant for investors monitoring company financial maneuvers and capital allocation.
Risk Assessment
Risk Level: low — The filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- GSK plc (company) — Registrant
- GlaxoSmithKline PLC (company) — Former company name
- 20250620 (date) — Filing date
- Form 6-K (document) — SEC filing type
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of this Form 6-K filing by GSK plc?
The Form 6-K filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, specifically detailing a 'Transaction in own shares' for the month of June 2025.
When was this filing made with the SEC?
The filing was conformed as of June 20, 2025, and the filing date is also listed as June 20, 2025.
What is GSK plc's principal executive office address?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Does GSK plc file its annual reports under Form 20-F or Form 40-F?
GSK plc indicates it files its annual reports under cover of Form 20-F.
What were GSK plc's former names?
GSK plc was formerly known as GSK PLC (with a name change date of 20220516) and prior to that, GlaxoSmithKline PLC (with a name change date of 20010105).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 20, 2025 regarding GSK plc (GLAXF).